Volume 140, Issue 7, Pages (June 2011)

Slides:



Advertisements
Similar presentations
Volume 141, Issue 2, Pages e2 (August 2011)
Advertisements

Volume 33, Issue 2, Pages (August 2010)
Cheng-Ming Sun, Edith Deriaud, Claude Leclerc, Richard Lo-Man  Immunity 
Volume 33, Issue 3, Pages (September 2010)
Volume 137, Issue 3, Pages (September 2009)
Volume 143, Issue 5, Pages (November 2012)
Juyang Kim, Wongyoung Kim, Hyun J. Kim, Sohye Park, Hyun-A
Identification of CD3+CD4−CD8− T Cells as Potential Regulatory Cells in an Experimental Murine Model of Graft-Versus-Host Skin Disease (GVHD)  Fumi Miyagawa,
Volume 141, Issue 1, Pages e1 (July 2011)
Volume 136, Issue 4, Pages e3 (April 2009)
Volume 135, Issue 6, Pages (December 2008)
Volume 136, Issue 3, Pages (March 2009)
Volume 130, Issue 2, Pages (February 2006)
Volume 34, Issue 3, Pages (March 2011)
Volume 143, Issue 5, Pages e4 (November 2012)
Redirection of Regulatory T Cells With Predetermined Specificity for the Treatment of Experimental Colitis in Mice  Eran Elinav, Tova Waks, Zelig Eshhar 
Effects and Regulation of Autoreactive CD8+ T Cells in a Transgenic Mouse Model of Autoimmune Hepatitis  Mario Zierden, Elisabeth Kühnen, Margarete Odenthal,
IL-21 inhibits T cell IL-2 production and impairs Treg homeostasis
Amelioration of Colitis by Genetically Engineered Murine Regulatory T Cells Redirected by Antigen-Specific Chimeric Receptor  Eran Elinav, Nitzan Adam,
Characterization of Interleukin-17–Producing Regulatory T Cells in Inflamed Intestinal Mucosa From Patients With Inflammatory Bowel Diseases  Zaruhi Hovhannisyan,
Volume 42, Issue 5, Pages (May 2015)
Volume 141, Issue 5, Pages (November 2011)
Volume 142, Issue 2, Pages e2 (February 2012)
Volume 141, Issue 2, Pages e2 (August 2011)
Volume 19, Issue 6, Pages (December 2003)
Volume 132, Issue 7, Pages (June 2007)
Volume 30, Issue 4, Pages (April 2009)
Volume 137, Issue 3, Pages (September 2009)
Volume 18, Issue 5, Pages (May 2003)
Volume 32, Issue 5, Pages (May 2010)
Volume 128, Issue 5, Pages (May 2005)
Volume 35, Issue 6, Pages (December 2011)
Volume 141, Issue 5, Pages (November 2011)
Volume 28, Issue 4, Pages (April 2008)
Volume 143, Issue 1, Pages (July 2012)
NKT Cells Inhibit the Onset of Diabetes by Impairing the Development of Pathogenic T Cells Specific for Pancreatic β Cells  Lucie Beaudoin, Véronique.
Volume 33, Issue 2, Pages (August 2010)
Volume 138, Issue 2, Pages (February 2010)
Volume 33, Issue 3, Pages (September 2010)
Volume 132, Issue 1, Pages (January 2007)
Volume 29, Issue 1, Pages (July 2008)
Volume 34, Issue 4, Pages (April 2011)
T Cell-Produced Transforming Growth Factor-β1 Controls T Cell Tolerance and Regulates Th1- and Th17-Cell Differentiation  Ming O. Li, Yisong Y. Wan, Richard.
Volume 135, Issue 5, Pages e5 (November 2008)
Antigen-Presenting Cell Production of IL-10 Inhibits T-Helper 1 and 17 Cell Responses and Suppresses Colitis in Mice  Bo Liu, Susan L. Tonkonogy, R. Balfour.
Volume 135, Issue 2, Pages e2 (August 2008)
Suppression of Murine Colitis and its Associated Cancer by Carcinoembryonic Antigen- Specific Regulatory T Cells  Dan Blat, Ehud Zigmond, Zoya Alteber,
Volume 29, Issue 6, Pages (December 2008)
Volume 36, Issue 2, Pages (February 2012)
Volume 142, Issue 5, Pages (May 2012)
Volume 141, Issue 5, Pages (November 2011)
Volume 36, Issue 6, Pages (June 2012)
Volume 33, Issue 4, Pages (October 2010)
CD8+ Cytotoxic T Cells Induce Relapsing Colitis in Normal Mice
Volume 135, Issue 3, Pages (September 2008)
Volume 34, Issue 3, Pages (March 2011)
Ana Belén Blázquez, Lloyd Mayer, M. Cecilia Berin  Gastroenterology 
Volume 17, Issue 2, Pages (February 2009)
Volume 29, Issue 5, Pages (November 2008)
Staphylococcal enterotoxin A–activated regulatory T cells promote allergen-specific TH2 response to intratracheal allergen inoculation  Wei-ping Zeng,
Volume 46, Issue 4, Pages (April 2017)
E3 Ubiquitin Ligase VHL Regulates Hypoxia-Inducible Factor-1α to Maintain Regulatory T Cell Stability and Suppressive Capacity  Jee H. Lee, Chris Elly,
Karima R.R. Siddiqui, Sophie Laffont, Fiona Powrie  Immunity 
Volume 34, Issue 3, Pages (March 2011)
Volume 41, Issue 2, Pages (August 2014)
Volume 30, Issue 4, Pages (April 2009)
Volume 131, Issue 6, Pages (December 2006)
Volume 35, Issue 1, Pages (July 2011)
Volume 32, Issue 5, Pages (May 2010)
Volume 13, Issue 11, Pages (December 2015)
Presentation transcript:

Volume 140, Issue 7, Pages 2031-2043 (June 2011) Interleukin-12 Converts Foxp3+ Regulatory T Cells to Interferon–γ-Producing Foxp3+ T Cells That Inhibit Colitis  Ting Feng, Anthony T. Cao, Casey T. Weaver, Charles O. Elson, Yingzi Cong  Gastroenterology  Volume 140, Issue 7, Pages 2031-2043 (June 2011) DOI: 10.1053/j.gastro.2011.03.009 Copyright © 2011 AGA Institute Terms and Conditions

Figure 1 Naïve CBir1-Tg T cells induce colitis and differentiate into various subsets in TCRβxδ−/− mice. TCRβxδ−/− mice were injected intravenously with phosphate-buffered saline or 1 × 106 naïve CD4+ T cells from CBir1-Tg or OT II mice. (A) Colonic histopathology of the recipients 8 weeks after cell transfer. (B and C) Spleen, MLN, and LP CD4+ T-cell cytokine were determined by flow cytometry 4 weeks (B) and 8 weeks (C) after cell transfer. Plot numbers represent the percentage of CD4+ T cells in the respective quadrants (left). Foxp3 negative or positive T cells were overlaid on CD4+ T cells, and the plot numbers represent the percentage of Foxp3 negative or positive T cells in the respective quadrants (right). Data are representative of 3 or more experiments with similar results. Gastroenterology 2011 140, 2031-2043DOI: (10.1053/j.gastro.2011.03.009) Copyright © 2011 AGA Institute Terms and Conditions

Figure 2 IL-12 and TGF-β are required for induction of Foxp3+IFN-γ+ T cells. CBir1-Tg CD4+ T cells were cultured with CBir1-peptide pulsed-splenic APC with various cytokines or antibody in the absence (A) or presence (B) of IL-2. Five days later, T-cell Foxp3 and IFN-γ expression was determined by flow cytometry and analyzed by gating on CD4+ population. (A and B) FACS profiles. One representative of at least 3 experiments was shown. (C) Bar chart represents aggregate data with mean ± standard error of mean of 3 experiments. Gastroenterology 2011 140, 2031-2043DOI: (10.1053/j.gastro.2011.03.009) Copyright © 2011 AGA Institute Terms and Conditions

Figure 3 CBir1-specific Foxp3+ Treg cells convert into IFN-γ+ and IL-17+ T cells in vivo. 0.5 × 106 Foxp3GFP + Treg cells were transferred into TCRβxδ−/− mice. (A) Four weeks later, cytokine production of transferred Treg cells was analyzed by flow cytometry by gating on CD4+ cells (left). Foxp3 negative or positive T cells were overlaid on CD4+ T cells, and the plot numbers represent the percentage of Foxp3 negative or positive T cells in the respective quadrants (right). (B) Colonic histology of the Treg cell or PBS recipients 8 weeks after transfer. Data are representative of 3 experiments. Gastroenterology 2011 140, 2031-2043DOI: (10.1053/j.gastro.2011.03.009) Copyright © 2011 AGA Institute Terms and Conditions

Figure 4 CBir1-specific Treg cell conversion to effector T cells takes place in the intestine. 0.5 × 106 Foxp3GFP+ Treg cells were transferred into TCRβxδ−/− mice. Two (A and B) and 6 weeks (C and D) later, cytokine production of transferred Treg cells was analyzed by flow cytometry by gating on CD4+ population or CD4+ Foxp3 negative population (A and C). (B and D) Bar chart represents aggregate data with mean ± standard error of 3 experiments (*P < .05; **P < .01). Data are representative of 2 (C and D) or 3 (A and B) experiments. Gastroenterology 2011 140, 2031-2043DOI: (10.1053/j.gastro.2011.03.009) Copyright © 2011 AGA Institute Terms and Conditions

Figure 5 IL-12 promotes Foxp3+ Treg cell conversion to IFN-γ-expressing T cells. (A–C) Foxp3GFP+ Treg cells were cultured with CBir1 peptide-pulsed splenic APC. Five days later, T-cells Foxp3 expression and IFN-γ production were determined by flow cytometry. Plot numbers represent the percentage of CD4+ population in the respective quadrants (A and C). Supernatant was collected on day 3 of cell culture, and IFN-γ production was determined by enzyme-linked immunosorbent assay (B). (D) 0.5 × 106 Foxp3GFP+ Treg cells were transferred into TCRβxδ−/− mice. The recipients were injected intraperitoneally with 100 μg of control or anti-IL-12p40 antibodies at the time of cell transfer and weekly thereafter. Four weeks later, cytokine production of transferred Treg cells was analyzed by flow cytometry with CD4+ T cells gated. Data represent 2 (D) or 3 (A–C) experiments with similar results. Gastroenterology 2011 140, 2031-2043DOI: (10.1053/j.gastro.2011.03.009) Copyright © 2011 AGA Institute Terms and Conditions

Figure 6 Th1 cells do not convert to Foxp3+ T cells, and Foxp3+IFN-γ+ T cells develop into IFN-γ+ but not Foxp3+ T cells. (A) IFN-γThy1.1+ Th1 cells from IFN-γThy1.1.CBir1-Tg mice were cultured with CBir1 peptide-pulsed splenic APC. Five days later, T-cell Foxp3 and IFN-γ expression was determined by flow cytometry by gating on CD4+ population. (B and C) 0.5 × 106 Th1 cells or PBS were transferred into TCRβxδ−/− mice, and the recipients were killed 10 weeks later. Colonic histopathology was assessed (B), and cytokine production of transferred CD4+ Th1 cells was analyzed by flow cytometry with CD4+ T cells gated (C). (D) 0.25 × 106 CBir1-specific Foxp3GFP-IFN-γThy1.1+, Foxp3GFP+IFN-γThy1.1−, and Foxp3GFP+IFN-γThy1.1+ T cells were transferred into RAG−/− mice. Eight weeks later, the recipients were killed, and cytokine production of transferred Treg cells was analyzed by flow cytometry. Plot numbers represent the percentage of CD4+ T cells in the respective quadrants. One of 3 experiments with similar results was shown. Gastroenterology 2011 140, 2031-2043DOI: (10.1053/j.gastro.2011.03.009) Copyright © 2011 AGA Institute Terms and Conditions

Figure 7 Foxp3+IFN-γ+ T cells retain regulatory functions. (A) 0.25 × 106 CBir1-Tg Foxp3GFP+IFN-γThy1.1− and Foxp3GFP+IFN-γThy1.1+ T cells were transferred into RAG−/− mice. The recipients were killed and colonic histopathology was analyzed 8 weeks later. (B) 0.2 × 106 CFSE-labeled CD4+ T cells from CD45.1 CBir1-Tg mice were cultured alone or with 0.2 × 106 CD45.2 CBir1-Tg Foxp3GFP+IFN-γThy1.1− or Foxp3GFP+IFN-γThy1.1+ T cells. T-cell proliferation was analyzed by flow cytometry based on the dilution of CFSE intensity by gating on CD4+CD45.1+ T cells. (C) 5 × 104 CD4+ T cells from CBir1-Tg mice were cultured alone or with 5 × 104 Foxp3GFP+IFN-γThy1.1− or Foxp3GFP+IFN-γThy1.1+ T cells. Tritiated thymidine was added for the last 8 hours of a 48-hour incubation period for T-cell proliferation. Mean CPM of triplicates ± standard error of mean are shown. (D and E) 0.25 × 106 CD45RBhi T cells from CBir1-Tg mice were transferred into RAG−/− mice alone or together with 0.25 × 106 Foxp3GFP+IFN-γThy1.1− or Foxp3GFP+IFN-γThy1.1+ T cells. Four weeks later, the recipients were killed, and histopathology was assessed. Combined colon and cecum histologic scores (D) and colonic histopathology (E) are shown. ***P < .001. Data represent 2 (D and E) or 3 (A–C) experiments with similar results. Gastroenterology 2011 140, 2031-2043DOI: (10.1053/j.gastro.2011.03.009) Copyright © 2011 AGA Institute Terms and Conditions